Urokinase 500000IU Injection
Marketer
TTK Healthcare Ltd
Salt Composition
Urokinase (500000IU)
Overview Urokinase 500000IU Injection
Urokinase 500000 IU injection dissolves dangerous blood clots obstructing blood vessels. This medication aids in the recovery of patients following a recent myocardial infarction. Further applications include treatment of pulmonary embolism and stroke. Administration is strictly under medical supervision; dosage and treatment length are determined individually by your physician, who will monitor your progress until stabilization. Potential side effects include nausea, vomiting, bleeding at the injection site, allergic responses, and hypotension. Increased bleeding risk is also a possibility. Your doctor will discuss the risks and benefits prior to treatment. Continue all prescribed medications as directed, even after the Urokinase injection. Pre-existing conditions, including bleeding disorders, kidney or liver disease, pregnancy, breastfeeding, and current medications, should be disclosed to your physician before treatment, as Urokinase use may require adjustments in such cases.
Uses of Urokinase 500000IU Injection
Myocardial infarction|Lung embolism
Major Benefits of Urokinase 500000IU Injection:
This medication will be administered by your physician or registered nurse; please do not attempt self-medication.
Common Side effects of Urokinase 500000IU Injection:
- Allergic reaction
- Nausea
- Vomiting
- Injection site bleeding
- Decreased blood pressure
How to use Urokinase 500000IU Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Urokinase 500000IU Injection works:
Urokinase 500000IU Injection facilitates the breakdown of dangerous blood clots within the circulatory system. This action reinstates blood circulation to compromised tissues, averting further tissue damage and improving clinical results.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Urokinase 500000IU Injection may pose unknown risks. Seek medical advice before combining them.
PregnancySAFE IF PRESCRIBED
The administration of 500,000 IU Urokinase injections is typically deemed safe for pregnant individuals. Preclinical trials using animal models revealed minimal or no harmful consequences for fetal development; nevertheless, data from human trials remain scarce.
Breast feedingSAFE IF PRESCRIBED
Breastfeeding mothers can likely use Urokinase 500000IU Injection safely. Available human data indicates minimal infant risk associated with this medication.
DrivingNOT RELEVANT
Urokinase 500000IU Injection is solely for inpatient administration.
KidneySAFE IF PRESCRIBED
Employing Urokinase 500000IU Injection in individuals with kidney disease appears to pose minimal risk. Preliminary findings indicate that dosage modification for Urokinase 500000IU Injection may be unnecessary in such cases. However, medical advice is essential. The administration of Urokinase 500000IU Injection is discouraged for patients exhibiting severe renal impairment.
LiverCAUTION
Patients with liver conditions should use Urokinase 500000IU Injection cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Urokinase 500000IU Injection :
Should you forget a dose of Urokinase 500000IU Injection, seek medical advice.
Facts to Know About Urokinase 500000IU Injection
| Label | Value |
|---|---|
| Chemical Type | Peptide and Amino Acid Analogs |
| Developing Habits | No. |
| Treatment Category | Heart |
| Actions | Early Thrombolytic Agents |
3,018 People bought this recently